Загрузка...
Multi-Crossover Randomized Controlled Trial Designs in Alzheimer’s Disease
Conventional parallel group randomized controlled clinical trials (RCT) in Alzheimer’s disease (AD) are too large, long, expensive and insensitive to clinical change to meet the urgent need for an effective treatment. While providing good evidence for a treatment’s benefit, parallel group RCTs in AD...
Сохранить в:
| Опубликовано в: : | Ann Neurol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6481185/ https://ncbi.nlm.nih.gov/pubmed/30014506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25280 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|